Skip to main content

Table 1 Clinical and molecular data on breast cancer patients (training set).

From: Predictors of primary breast cancers responsiveness to preoperative Epirubicin/Cyclophosphamide-based chemotherapy: translation of microarray data into clinically useful predictive signatures

Case

Response

Tumor reduction,%

Histology pre

Age

ER

PR

BCL2

P53

KI67,%

CerbB2

Grading

BC1492

NC

0

invasive lobular

50

0

0

0

1

28

0

2

BC1426

NC

0

invasive ductal + intraductal(40%)

62

1

1

400

0

2

1+ to 2+

1 a. 2

BC1257

NC

0

invasive lobular

69

1

1

180

0

16

1+ to 2+

2

BC1176

NC

0

invasive lobular a. tubular-lobular

47

1

1

130

0

7

0

2

BC1092

NC

0

invasive lobular a. ductal

66

1

1

0

0

10

0

2

BC1050

NC

0

invasive tubular-lobular; multifocal

60

1

1

60

0

3

0

2

BC1034

NC

0

intraductal a. invasive

43

1

1

0

0

2

0

2

BC1044

NC

0

invasive tubular-lobular

68

1

1

70

0

6

0

1

BC1466

pCR

100

invasive ductal a. intraductal(30%)

57

0

0

0

0

26

3+

2

BC1255

pCR

100

invasive lobular

57

1

0

60

1

26

0

2

BC1254

pCR

100

medullary

62

0

0

0

0

70

1+

3

BC1180

pCR

100

invasive lobular a. ductal

32

0

0

0

0

20

1+

2

BC1159

pCR

100

invasive lobular a. ductal

40

0

0

70

0

70

1+ to 2+

2

BC1042

pCR

100

non-typical medullary a. intraductal (bifocal)

38

0

0

10

0

35

0

3

BC1032

pCR

100

invasive lobular a. ductal

58

0

0

0

0

15

3+

2

BC1443

PR/CR

94

invasive lobular a. ductal

61

1

0

10

0

30

3+

2

BC1167

PR

0

invasive lobular

71

1

1

400

0

8

0

2

BC1162

PR

0

invasive lobular

66

1

1

70

0

7

1+

2

BC1143

PR

0

invasive ductal a. intraductal(5%)

54

1

1

210

0

17

1+

2

BC1138

PR

0

invasive lobular; multifocal

57

1

1

80

0

13

1+

2

BC1100

PR

0

invasive tubular-lobular

55

1

1

140

0

4

0

1

BC1040

PR

0

invasive ductal

40

1

1

294

0

28

0

2

BC1170

PR

0

invasive lobular a. ductal bifocal

67

1

0

210

0

4

2+ to 3+

2

BC1140

PR

10

left: invasive lobular

73

1

1

180

0

14

0

2

BC1418

PR

12

left:bifocal invasive tubular-lobular

57

1

0

300

0

7

2+

1

BC1420

PR

15

invasive ductal a. lobular; multifocal

63

1

1

400

0

3

2+

2

BC1491

PR

18

invasive lobular

64

1

1

300

0

7

0

2

BC1515

PR

20

invasive ductal

64

1

1

300

1

10

0

2

BC1445

PR

20

right:invasive lobular; bifocal

64

1

0

160

0

15

1+ to 2+

2

BC1036

PR

24

invasive ductal

58

1

1

392

0

15

0

2

BC1308

PR

25

invasive lobular; multifocal

74

0

0

0

0

16

2+

2

BC1133

PR

25

invasive ductal

53

0

0

294

0

50

0

3

BC1259

PR

32

invasive ductal a. lobular (Herd1) a. invasive ductal (Herd2)

59

1

0

300

0

16

2+ to 3+

2

BC1498

PR

33

invasive ductal; bifocal

62

1

0

15

0

19

3+

3

BJ_40613

PR

35

invasive ductal

61

1

1

100

0

4

2+

2

BC1166

PR

35

invasive ductal a. lobular

45

1

1

140

0

14

1+ to 2+

2

BC1142

PR

35

invasive lobular; bifocal

53

1

1

20

0

18

1+

2

BC1422

PR

40

invasive ductal a. lobular; multifocal

53

1

1

360

0

2

2+

2

BC1132

PR

40

invasive ductal

41

1

1

30

1

18

2+

3

BC1096

PR

40

invasive ductal

46

1

1

294

0

13

0

2

BC1129

PR

42

invasive tubular-lobular

52

0

0

0

0

15

2+

2

BC1130

PR

45

invasive lobular

42

1

1

140

0

NA

0

2

BC1131

PR

45

invasive ductal (pulmonal, ossar)

63

1

0

300

0

45

0

2

BC1256

PR

50

invasive lobular

60

0

0

0

1

17

1+

2

BC1446

PR

50

invasive lobular; bifocal

53

1

1

140

0

35

1+

2

BC1116

PR

53

invasive lobular

49

1

1

180

0

3

0

2

BC1415

PR

55

invasive lobular; multifocal

53

0

0

15

1

40

0

2

BC1141

PR

55

invasive lobular

52

1

1

500

0

20

0

2

BC1495

PR

60

invasive tubular a. intraductal (10%); bifocal

58

1

0

300

0

2

0

2

BC1497

PR

75

invasive lobular

42

1

1

300

0

5

2+

2

BC1160

PR

75

invasive lobular

47

0

1

30

0

35

0

2

BC1038

PR

75

invasive ductal

35

1

1

294

0

30

0

2

BC1095

PR

85

invasive tubular-lobular

60

1

0

294

0

1

0

1

BC1024

PR

88

invasive lobular

59

1

1

70

0

18

0

2

BC1101

PR

75–85

invasive lobular; multifocal

75

1

0

180

0

10

3+

2

BC1139

PR

89–90

invasive lobular with DCIS parts; multifocal

55

1

1

NA

0

15

NA

1

  1. ER and PgR status were determined by immunohistochemistry. 1 – positive (>7 fmol/mg protein); 0 – negative (<7 fmol/mg protein). HER2/neu status: copies of HER2/neu gene. Status of p53 oncogene: 0 - <180 score; 1 - >180 score. NA – not available.